Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $181.1 million.

  • Accendra Health's Cash from Financing Activities rose 19073.59% to $181.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.5 million, marking a year-over-year increase of 19519.66%. This contributed to the annual value of -$267.6 million for FY2024, which is 3587.74% up from last year.
  • Latest data reveals that Accendra Health reported Cash from Financing Activities of $181.1 million as of Q3 2025, which was up 19073.59% from $31.7 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Cash from Financing Activities registered a high of $1.7 billion during Q1 2022, and its lowest value of -$199.6 million during Q3 2024.
  • For the 5-year period, Accendra Health's Cash from Financing Activities averaged around $52.0 million, with its median value being -$51.2 million (2023).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 217004.75% in 2022, then crashed by 81278.43% in 2023.
  • Accendra Health's Cash from Financing Activities (Quarter) stood at -$12.3 million in 2021, then tumbled by 417.95% to -$63.5 million in 2022, then grew by 19.32% to -$51.2 million in 2023, then increased by 15.85% to -$43.1 million in 2024, then soared by 520.22% to $181.1 million in 2025.
  • Its Cash from Financing Activities was $181.1 million in Q3 2025, compared to $31.7 million in Q2 2025 and $92.8 million in Q1 2025.